tt301
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2011 (NCT01357421)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tt301
- tt301
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02942771 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2017 | Alzheimer's Association, Duke University, University of Kentucky |
| NCT01357421 | Phase 1 | May 1, 2011 | Transition Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alzheimer's Association | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Duke University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Transition Therapeutics | For profit | 1 | 1 | 1 | 2011 |
| University of Kentucky | Academic/Hospital | 1 | 1 | 1 | 2017 |
4 organizations
Page 1 / 1